» Articles » PMID: 31241800

LncRNA DGCR5 Regulates the Non-small Cell Lung Cancer Cell Growth, Migration, and Invasion Through Regulating MiR-211-5p/EPHB6 Axis

Overview
Journal Biofactors
Publisher IOS Press
Specialty Biochemistry
Date 2019 Jun 27
PMID 31241800
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Non-small cell lung cancer (NSCLC) accounts for about 80% of lung cancers worldwide. In recent years, importance of noncoding RNAs including long noncoding RNA and microRNA in regulating tumor progression has been appreciated. Abnormally expression of DiGeorge syndrome critical region gene 5 (DGCR5) was found in multiple human cancers but its function in NSCLC is largely unknown. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was conducted to explore DGCR5 expression level in NSCLC. Bioinformatic analyses were conducted to explore the targets of DGCR5. Cell counting kit-8 assay, wound-healing assay, and transwell invasion assay were performed to analyze functions of DGCR5. RT-qPCR revealed that DGCR5 expression in NSCLC cells was significantly lower than in normal cell. DGCR5 overexpression suppresses NSCLC cell growth, migration, and invasion. Online algorithms found EPH receptor B6 (EPHB6) and DGCR5 contains same miR-211-5p binding region. The predicted connections were further validated by luciferase activity reporter assay. Recue experiments showed DGCR5 regulates NSCLC cell behaviors via targeting miR-211-5p/EPHB6. These findings collectively identified DGCR5/miR-211-5p/EPHB6 triple axis in NSCLC, which may novel understanding regarding the tumorigenesis of NSCLC.

Citing Articles

Erythropoietin-producing hepatocellular receptor B6 is highly expressed in non-functioning pituitary neuroendocrine tumors and its expression correlates with tumor size.

Rubinfeld H, Cohen Z, Bendavid U, Fichman-Horn S, Levy-Barda A, David C Mol Biol Rep. 2024; 51(1):297.

PMID: 38341842 PMC: 10859332. DOI: 10.1007/s11033-023-09186-7.


Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village.

Ao Y, Gao J, Jiang J, Wang H, Wang S, Ding J Mol Ther. 2023; 31(12):3389-3413.

PMID: 37740493 PMC: 10727995. DOI: 10.1016/j.ymthe.2023.09.015.


Aberrant Expression and Prognostic Potential of IL-37 in Human Lung Adenocarcinoma.

Christodoulou P, Kyriakou T, Boutsikos P, Andreou M, Ji Y, Xu D Biomedicines. 2022; 10(12).

PMID: 36551790 PMC: 9775426. DOI: 10.3390/biomedicines10123037.


LncRNA MNX1-AS1 contributes to lung adenocarcinoma progression by targeting the miR-34a/SIRT1 axis.

Liu G, Zhang Y, Zhang X, Liu Y, Xu Y, Cui S Am J Transl Res. 2022; 14(7):4977-4989.

PMID: 35958481 PMC: 9360842.


Role and mechanism of miR-211 in human cancer.

Ye L, Wang F, Wang J, Wu H, Yang H, Yang Z J Cancer. 2022; 13(9):2933-2944.

PMID: 35912006 PMC: 9330454. DOI: 10.7150/jca.71401.